Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

AZD2171 to Treat Children and Adolescents With Solid Tumors or Acute Myelogenous Leukemia

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00321581
First received: May 3, 2006
Last updated: November 18, 2016
Last verified: June 2012